The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients.
Por:
Gonzalez EO, Boix V, Deltoro MG, Aldeguer JL, Portilla J, Montero M, Belda EB, Abril V, Gutierrez F, Minguez C, Galindo J, Benirto C, Rodriguez MG, Giner L, Rubio P, Uso J and Llerena G
Publicada:
2 nov 2014
Resumen:
The fibrogenesis analysis in quimeric CCR1 and CCR5 mice revealed that CCR5 mediates its pro-fibrogenic effects in hepatic cells and promoting stellate cells. The blockage of co-receptors could preserve the progression of hepatic fibrosis in HIV/HCV co-infected patients.
Filiaciones:
Gonzalez EO:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
Boix V:
Infectious Disease Unit, Hospital General Universitario de Alicante, Valencia, Spain
Deltoro MG:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
Aldeguer JL:
Infectious Disease Unit, Hospital La Fe Universitario de Valencia, Valencia, Spain
Portilla J:
Infectious Disease Unit, Hospital General Universitario de Alicante, Alicante, Spain
Montero M:
Infectious Disease Unit, Hospital La Fe Universitario de Valencia, Valencia, Spain
Belda EB:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
Abril V:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
:
Infectious Disease Unit, Hospital General Universitario de Elche, Elche, Alicante, Spain
:
Infectious Disease Unit, Hospital General Universitario de Castellon, Castellon de la Plana, Spain
Galindo J:
Infectious Disease Unit, Hospital Clinico Universitario de Valencia, Valencia, Spain
:
Infectious Disease Unit, Hospital General de la Marina Baja, Villajoyosa, Alicante, Spain
Rodriguez MG:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
Giner L:
Infectious Disease Unit, Hospital General Universitario de Alicante, Alicante, Spain
Rubio P:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
Uso J:
Infectious Disease Unit, Hospital General Universitario de Castellon, Castellon de la Plana, Spain
Llerena G:
Infectious Disease Unit, Hospital General Universitario de Valencia, Valencia, Spain
|